Company Filing History:
Years Active: 1998-2019
Title: **Innovator Spotlight: Charanjit R Behl**
Introduction
Charanjit R Behl is a notable inventor based in Hauppauge, NY, who has made significant contributions to the field of pharmaceutical sciences. With a portfolio of 10 patents, Behl is recognized for his innovative approaches in developing formulations aimed at enhancing medication safety and efficacy.
Latest Patents
Among his latest innovations, Behl has focused on developing abuse-resistant oral dosage forms. These inventions incorporate a compressed microtablet design, coated with a water-retardant polymer. This unique formulation aims to mitigate the risks associated with opioid medications by combining an opioid agonist with at least one microtablet that may also contain an opioid antagonist. The innovations aim to provide safer alternatives in pain management therapies, addressing a growing concern regarding substance abuse.
Career Highlights
Throughout his career, Charanjit R Behl has been associated with prominent companies such as Nastech Pharmaceutical Company, Inc. and Elite Laboratories, Inc. His endeavors in these organizations highlight his commitment to advancing pharmaceutical technology and improving patient outcomes through innovative solutions.
Collaborations
Behl has worked alongside esteemed colleagues, including Vincent D Romeo and Anthony P Sileno. Their collaborative efforts have contributed to enhancing the development and understanding of pharmaceutical formulations, further establishing their reputations as leading figures in the industry.
Conclusion
Charanjit R Behl exemplifies the spirit of innovation in the pharmaceutical field. His contributions play a critical role in developing safer medication alternatives, showcasing the impact of creativity and scientific inquiry in addressing public health challenges. With a solid patent portfolio and a dedication to collaboration, Behl continues to be a significant figure in the realm of pharmaceutical innovations.